SARMs, explained: what they are, what the evidence says, and why they're not the shortcut they're sold as

SARMs are sold online as the smart shortcut: the muscle-building pull of steroids without the downsides, neatly "targeted" to your muscle and bone. The reality is harder. Not one SARM has ever been approved for any medical use anywhere, after roughly two decades of trials. They carry documented harms — testosterone suppression, liver injury, cholesterol crashes, cardiovascular signals — with no long-term human safety data to lean on. And the products themselves are so often mislabelled or spiked that many buyers genuinely don't know what's in the bottle.

This is informational coverage, not medical advice, and it is not a how-to. There is no dosing, no protocol and nothing about where to get these. If any of this is relevant to you, the answer is the same one we give for every drug on this beat: talk to a qualified clinician.

What SARMs actually are — and the promise that sells them

SARMs are selective androgen receptor modulators. They work by selectively activating the androgen receptors in muscle and bone, which is the entire basis of the marketing pitch: target the tissues you want, skip the broader effects of anabolic steroids, get most of the upside with fewer side effects.

That's the theory. The selectivity is real enough to be interesting to drug developers, which is why companies have spent years running trials. But "more selective than a steroid" is not the same as "safe", and the long-term safety profile in healthy people has never been established. The pitch describes the hoped-for advantage of the drug class. It quietly skips the part where that advantage was never confirmed to be safe in the people actually buying it.

Common names you'll see marketed include ostarine (MK-2866), ligandrol (LGD-4033), testolone (RAD-140), andarine, cardarine and YK-11, plus MK-677, which gets sold alongside them.

The evidence problem: lots of trials, zero approvals

Here is the single fact that collapses the "it's basically a medicine" framing. Despite more than twenty years of development, no SARM has been approved by the FDA, the EMA, or any regulatory body, for any medical use. They are all still investigational drugs. The FDA states plainly that SARMs are not approved, cannot be legally sold as supplements or as drugs, and are associated with serious or life-threatening health problems.

The most clinically advanced SARM shows why. Enobosarm — the medical name for ostarine — reached large Phase 3 trials in cancer-related muscle wasting. It did improve lean body mass. But it failed to improve physical function and muscle strength, which is the benefit regulators actually require, so it was not approved. More lean mass on a scan did not translate into a body that worked better. If the best-studied SARM couldn't clear that bar, the rest are nowhere near it.

Bottom line

After 20-plus years of trials, not a single SARM has been approved for any medical use anywhere. They are unapproved investigational drugs, not medicines.

The real risks, named plainly

This is not a theoretical hazard list. A 2023 systematic review pulled together 33 studies — 18 clinical trials and 15 case reports — covering more than 1,400 people exposed to SARMs. The findings are consistent and unflattering.

Testosterone suppression. Trials show reductions in total testosterone with ligandrol (LGD-4033), testolone (RAD-140) and ostarine (MK-2866). The "it won't shut down your own testosterone like steroids do" claim is wrong; suppression is documented. The FDA links SARM use to testicular shrinkage, infertility, sexual dysfunction, and — in men whose partners are affected — miscarriage.

Liver injury. Elevated liver enzymes turned up commonly in the trials. The case reports are worse: drug-induced liver injury, with reports since 2020 of cholestatic or hepatocellular damage and jaundice, predominantly in young men aged 19 to 40, linked to ligandrol, ostarine and RAD-140. One published case describes a 24-year-old man who developed cholestatic liver injury with jaundice after just five weeks on RAD-140, confirmed by biopsy. The idea that liver damage only comes from heavy, long-term use does not survive contact with the literature.

Cholesterol and the heart. Eight trials reported dose-dependent reductions in HDL — the "good" cholesterol — which were reversible on stopping but real while taking them. On the cardiovascular side, there is a published case of acute myocarditis, inflammation of the heart muscle, temporally linked to RAD-140 use. The FDA's own list of SARM-associated harms includes increased risk of heart attack and stroke.

Beyond those, the FDA flags acute liver failure requiring hospitalisation, psychosis and hallucinations, and sleep disturbances. Singapore's Health Sciences Authority lists insomnia, irritability, aggression, hypertension and impotence among possible effects. None of this is the "clean" profile the ads promise.

A 24-year-old developed biopsy-confirmed liver injury with jaundice after five weeks on a single SARM — the kind of harm the "fewer side effects than steroids" pitch leaves out.

What's actually in the bottle

Even if you accepted the risk, you could not trust the product. In a chemical analysis of 44 items sold online as SARMs, only about 41% actually contained a compound matching the label. Around a quarter contained the listed compound at a different dose than stated. And 39% contained a different unapproved drug entirely — a steroid or a growth-hormone agent — that wasn't on the label at all.

So when something goes wrong, the buyer often has no idea what caused it, because the bottle and the contents don't match. This is why the "for research use only" or "not for human consumption" wording on the label matters. It is not a sign of a high-purity research compound. It is a legal workaround for an unregulated market — and in that market a bottle may hold a tiny fraction of the claimed compound, a toxic excess, or something else altogether.

The legal and sporting reality

SARMs are banned at all times in sport — in and out of competition — under section S1.2, "Other Anabolic Agents", of the WADA Prohibited List. Ostarine, andarine, ligandrol and RAD-140 are named examples that keep turning up in products sold illegally. The ban is not an arbitrary sport rule; it reflects that these are anabolic agents with real physiological effects. And because contamination is rife, athletes have failed drug tests from products they never knowingly took a SARM from.

In Singapore, SARMs are controlled under the Poisons Act. HSA states that no SARM has been approved for clinical use in humans, and selling or supplying them without authorisation is illegal. This is enforced: in 2024, HSA seized 970,707 units of illegal health products and removed 7,351 listings from local e-commerce and social media platforms. "Sold openly online" does not mean legal.

Why this isn't the shortcut it's sold as

Pull the threads together. SARMs are unproven — no approval anywhere after twenty years of trials. They are unregulated — illegal to sell as supplements or drugs, controlled under the Poisons Act here, banned in sport. They are often fake — most products don't match their label, and many are spiked with other drugs. And they carry real, sometimes serious harm, including liver injury in healthy young men after only a few weeks.

A genuine shortcut is cheaper, faster and safe. This is none of those. The authors of that 2023 systematic review put it bluntly: recreational SARM use should be strongly discouraged, and long-term safety in healthy people is not established. That is the honest summary.

If you're weighing this up, the cautious read is the simple one: skip it, and take any specific question to a qualified doctor. This article is informational only and not a substitute for personalised medical advice.

Sources

The Catalyst Feed

Content TeamIndependent, hands-on coverage of health, fitness & the tech that tracks it. Reviews you can trust — no hype.

#sarms #peds-explained #muscle-building #drug-safety #ymyl #supplements #doping #liver-health